Index by author
January 01, 2012; Volume 79,Issue 1
Abdulbaki, Abdulrahman
- You have accessCytomegalovirus colitisJana G. Hashash, MD, Marwan Refaat, MD, Abdulrahman Abdulbaki, MD, Elie G. Aoun, MD and Leonard Baidoo, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 12-13; DOI: https://doi.org/10.3949/ccjm.78a.11028
Agyemang, Charles
- You have accessOvercoming barriers to hypertension control in African AmericansTaiye Odedosu, MD, Antoinette Schoenthaler, EdD, Dorice L. Vieira, MLS, MPH, MA, Charles Agyemang, PhD and Gbenga Ogedegbe, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 46-56; DOI: https://doi.org/10.3949/ccjm.79a.11068
Alraies, M. Chadi
- You have accessShould target natriuretic peptide levels be used for outpatient management of chronic heart failure?Ahmed Ibrahim, MD, Motaz Baibars, MD, M. Chadi Alraies, MD, FACP and Guilherme H. Oliveira, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 22-25; DOI: https://doi.org/10.3949/ccjm.79a.11066
Aoun, Elie G.
- You have accessCytomegalovirus colitisJana G. Hashash, MD, Marwan Refaat, MD, Abdulrahman Abdulbaki, MD, Elie G. Aoun, MD and Leonard Baidoo, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 12-13; DOI: https://doi.org/10.3949/ccjm.78a.11028
Baibars, Motaz
- You have accessShould target natriuretic peptide levels be used for outpatient management of chronic heart failure?Ahmed Ibrahim, MD, Motaz Baibars, MD, M. Chadi Alraies, MD, FACP and Guilherme H. Oliveira, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 22-25; DOI: https://doi.org/10.3949/ccjm.79a.11066
Baidoo, Leonard
- You have accessCytomegalovirus colitisJana G. Hashash, MD, Marwan Refaat, MD, Abdulrahman Abdulbaki, MD, Elie G. Aoun, MD and Leonard Baidoo, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 12-13; DOI: https://doi.org/10.3949/ccjm.78a.11028
Fernandez, Hubert H.
- You have accessUpdates in the medical management of Parkinson diseaseHubert H. Fernandez, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 28-35; DOI: https://doi.org/10.3949/ccjm.78gr.11005
Most, if not all, currently available drugs for Parkinson disease address dopaminergic loss and relieve symptoms. However, their adverse effects can be limiting and they do not address disease progression. Moreover, nonmotor features of Parkinson disease such as depression, dementia, and psychosis are now recognized as important and disabling. A cure remains elusive. However, promising interventions and agents are emerging. As an example, people who exercise regularly are less likely to develop Parkinson disease, and if they develop it, they tend to have slower progression.
Haessler, Sarah
- You have accessManaging community-acquired pneumonia during flu seasonSarah Haessler, MD and Jennifer J. Schimmel, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 67-78; DOI: https://doi.org/10.3949/ccjm.79a.11108
Hashash, Jana G.
- You have accessCytomegalovirus colitisJana G. Hashash, MD, Marwan Refaat, MD, Abdulrahman Abdulbaki, MD, Elie G. Aoun, MD and Leonard Baidoo, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 12-13; DOI: https://doi.org/10.3949/ccjm.78a.11028
Ibrahim, Ahmed
- You have accessShould target natriuretic peptide levels be used for outpatient management of chronic heart failure?Ahmed Ibrahim, MD, Motaz Baibars, MD, M. Chadi Alraies, MD, FACP and Guilherme H. Oliveira, MDCleveland Clinic Journal of Medicine January 2012, 79 (1) 22-25; DOI: https://doi.org/10.3949/ccjm.79a.11066